NCT04848545View on ClinicalTrials.gov

Endocrine Disrupting Chemical Exposure and Testicular Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2030

Conditions
Testicular Cancer
Interventions
OTHER

Observational

Prenatal maternal exposure to endocrine disrupting chemicals

Trial Locations (2)

2100

Department of Growth and Reproduction, Rigshospitalet, Copenhagen

EDMaRC, Rigshospitalet secton 5064, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER